| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The epidemiology of sepsis in the United States from 1979 through 2000.
|
N Engl J Med
|
2003
|
32.30
|
|
2
|
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
|
JAMA
|
2016
|
17.49
|
|
3
|
Severe sepsis and septic shock.
|
N Engl J Med
|
2013
|
14.31
|
|
4
|
Drotrecogin alfa (activated) in adults with septic shock.
|
N Engl J Med
|
2012
|
9.19
|
|
5
|
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.
|
JAMA
|
1994
|
5.24
|
|
6
|
Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.
|
N Engl J Med
|
1991
|
4.66
|
|
7
|
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.
|
JAMA
|
2003
|
4.54
|
|
8
|
A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
|
N Engl J Med
|
1992
|
4.25
|
|
9
|
Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
|
J Clin Apher
|
2010
|
3.47
|
|
10
|
Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
|
Lancet
|
1997
|
2.36
|
|
11
|
Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure.
|
Crit Care Med
|
2008
|
1.97
|
|
12
|
Blood purification and mortality in sepsis: a meta-analysis of randomized trials.
|
Crit Care Med
|
2013
|
1.94
|
|
13
|
INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.
|
Crit Care Med
|
1996
|
1.73
|
|
14
|
Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group.
|
Crit Care Med
|
1999
|
1.65
|
|
15
|
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.
|
Intensive Care Med
|
2017
|
1.54
|
|
16
|
Comparative analysis of therapeutic options used for myasthenia gravis.
|
Ann Neurol
|
2010
|
1.46
|
|
17
|
Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial.
|
Intensive Care Med
|
2002
|
1.33
|
|
18
|
Plasmapheresis for meningococcemia with disseminated intravascular coagulation.
|
N Engl J Med
|
1979
|
1.19
|
|
19
|
Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis.
|
BMJ
|
2007
|
1.14
|
|
20
|
Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange.
|
Br Med J (Clin Res Ed)
|
1984
|
1.14
|
|
21
|
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.
|
J Clin Apher
|
2016
|
1.05
|
|
22
|
Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research.
|
J Clin Apher
|
2013
|
1.00
|
|
23
|
Role of exchange transfusion in the treatment of severe septicemia.
|
Pediatrics
|
1980
|
0.99
|
|
24
|
Comparison of IVIg and PLEX in patients with myasthenia gravis.
|
Neurology
|
2011
|
0.99
|
|
25
|
Plasma exchange in severe attacks of neuromyelitis optica.
|
Mult Scler Int
|
2012
|
0.90
|
|
26
|
Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients.
|
BMC Anesthesiol
|
2014
|
0.87
|
|
27
|
Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: A retrospective review.
|
J Clin Apher
|
2015
|
0.83
|
|
28
|
A randomised controlled trial of plasma filtration in severe paediatric sepsis.
|
Crit Care Resusc
|
2013
|
0.82
|
|
29
|
Plasmapheresis in the treatment of primary septic shock in humans.
|
Scand J Infect Dis
|
1993
|
0.81
|
|
30
|
A review of plasma exchange in sepsis.
|
Blood Purif
|
2002
|
0.77
|
|
31
|
Sepsis and septic shock: Pathogenesis and treatment perspectives.
|
J Crit Care
|
2017
|
0.75
|
|
32
|
Which Multicenter Randomized Controlled Trials in Critical Care Medicine Have Shown Reduced Mortality? A Systematic Review.
|
Crit Care Med
|
2019
|
0.75
|
|
33
|
Apheresis for severe malaria complicated by cerebral malaria, acute respiratory distress syndrome, acute renal failure, and disseminated intravascular coagulation.
|
J Clin Apher
|
1992
|
0.75
|